Umbralisib Tosylate

Generic Name: umbralisib tosylate

Over-the-Counter (OTC)

Manufactured by TG THERAPS. Dosage form: TABLET. Route: ORAL. Active ingredients: UMBRALISIB TOSYLATE (EQ 200MG BASE). Application: NDA213176.

Overview

Manufactured by TG THERAPS. Dosage form: TABLET. Route: ORAL. Active ingredients: UMBRALISIB TOSYLATE (EQ 200MG BASE). Application: NDA213176.

Dosage

Available as tablet for oral use.

Related Medications

Ritonavir Form Ii

ritonavir form ii

Dosage form: POWDER. Active ingredients: RITONAVIR (1 kg/kg). Category: BULK INGREDIENT.

11 DESCRIPTION PIQRAY (alpelisib) is a kinase inhibitor. The chemical name of alpelisib is (2S)- N 1 -[4-Methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl]-2-thiazolyl]-1,2-pyrrolidinedicarboxamide. Alpelisib is a white to almost white powder. The molecular formula for alpelisib is C 19 H 22 F 3 N 5 O 2 S and the relative molecular mass is 441.47 g/mol.

Sparsentan

sparsentan

Endothelin Receptor Antagonist [EPC]

11 DESCRIPTION FILSPARI (sparsentan) is an endothelin and angiotensin II receptor antagonist. The chemical name of sparsentan is 2-[4-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2-(ethoxymethyl)phenyl]-N-(4,5-dimethyl-1,2-oxazol-3-yl)benzenesulfonamide. Sparsentan is a white to off-white powder, which is practically insoluble in water. Sparsentan has pH-dependent solubility, with intrinsic solubility of 1.48 and 0.055 mg/mL under pH 1.2 and 6.8, respectively.

Medical Disclaimer

This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.